Company
Dice Therapeutics
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Developing innovative medicines in immunology.
About the company
- Status notes
- acquisition by Lilly for $2.4B
Exit
- Acquisition
- $2.4B$2.4B
Loading relationship preview